Payer executives expressed confidence in the continuation of enhanced ACA subsidies in some form past 2025. 

The percentage of healthcare risk dollars in two-sided risk arrangements grew across all types of health plans in 2023, according to the Healthcare Payment Learning and Action Network's annual report. 

CMS will give less weight to call center metrics in future Medicare Advantage star ratings, according to a top CMS official. 

From announcing plans to buy CareBridge to suing CMS over its Medicare Advantage star ratings, here are 10 updates on Elevance Health that Becker's has reported since Oct. 17:

Two Blue Cross Blue Shield plans have now lost in federal court for terminating employees that refused to get vaccinated against COVID-19, and other insurers are facing similar lawsuits.

California has the highest number of individuals with Medicare Part D coverage, while Washington, D.C. has the lowest amount, according to KFF.

Michigan has canceled contracts with nine health plans to manage the state's Medicaid program for individuals dually-eligible for Medicare and Medicaid. 

Elevance Health is focusing its attention on markets with the most disruption during Medicare Advantage open enrollment, CFO Mark Kaye told investors. 

KFF Health News is suing HHS to release audits of Medicare Advantage plans and other records, the health news outlet reported Nov. 12. 

UnitedHealth Group's board of directors authorized a $2.10 per-share cash dividend to be paid on Dec. 17. 

Medical Mutual has named an interim CEO, with current CEO Steven Glass set to exit. 

What do you do when there’s an oligopoly controlling an industry, inhibiting price competition and consumer choice? You break it up. The three dominant pharmacy benefit managers (PBMs), CVS Caremark, Cigna’s Express Scripts and United’s OptumRx are drug-pricing middlemen, increasing costs and limiting choice for more than 200 million Americans. Collectively, they process more than 80% of prescriptions in the U.S., up from 50% in 2012. It’s time for their hold on employers and consumers to end.

Cigna directly confirmed on Nov. 11 that it is not pursuing a merger with Humana and said it "continues to deliver shareholder value through focused execution against stated operational and financial targets, and via disciplined capital deployment including dividends and share repurchase." 

Centene subsidiary Sunshine Health Plan has named Charlene Zein plan president and CEO. 

Centene president Ken Fasola plans to retire in July 2025. 

Humana has named Michelle O'Hara as chief human resources officer. 

The U.S. Justice Department is suing UnitedHealth Group and home health company Amedisys over the companies' planned $3.3 billion merger.

Ten providers recently posted job listings seeking leaders in payer contracting and relations.

Centene CEO Sarah London bought 4,117 shares of the company's stock, according to a Nov. 8 SEC filing. 

Medicare Advantage insurers are ramping up efforts to persuade lawmakers to increase funding for the program, Politico reported Nov. 11.